1. Home
  2. ADXN vs JNVR Comparison

ADXN vs JNVR Comparison

Compare ADXN & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • JNVR
  • Stock Information
  • Founded
  • ADXN 2002
  • JNVR 2018
  • Country
  • ADXN Switzerland
  • JNVR United States
  • Employees
  • ADXN N/A
  • JNVR N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • JNVR Finance: Consumer Services
  • Sector
  • ADXN Health Care
  • JNVR Finance
  • Exchange
  • ADXN Nasdaq
  • JNVR Nasdaq
  • Market Cap
  • ADXN 8.0M
  • JNVR 7.3M
  • IPO Year
  • ADXN N/A
  • JNVR 2023
  • Fundamental
  • Price
  • ADXN $7.59
  • JNVR $5.29
  • Analyst Decision
  • ADXN Strong Buy
  • JNVR
  • Analyst Count
  • ADXN 1
  • JNVR 0
  • Target Price
  • ADXN $30.00
  • JNVR N/A
  • AVG Volume (30 Days)
  • ADXN 24.5K
  • JNVR 18.8K
  • Earning Date
  • ADXN 03-24-2025
  • JNVR 03-27-2025
  • Dividend Yield
  • ADXN N/A
  • JNVR N/A
  • EPS Growth
  • ADXN N/A
  • JNVR N/A
  • EPS
  • ADXN 0.06
  • JNVR N/A
  • Revenue
  • ADXN $701,260.00
  • JNVR $1,820,969.00
  • Revenue This Year
  • ADXN N/A
  • JNVR N/A
  • Revenue Next Year
  • ADXN N/A
  • JNVR N/A
  • P/E Ratio
  • ADXN $1.04
  • JNVR N/A
  • Revenue Growth
  • ADXN N/A
  • JNVR N/A
  • 52 Week Low
  • ADXN $6.81
  • JNVR $3.37
  • 52 Week High
  • ADXN $27.90
  • JNVR $11.84
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 48.97
  • JNVR 49.60
  • Support Level
  • ADXN $7.20
  • JNVR $4.88
  • Resistance Level
  • ADXN $8.04
  • JNVR $5.61
  • Average True Range (ATR)
  • ADXN 0.51
  • JNVR 0.63
  • MACD
  • ADXN 0.00
  • JNVR -0.03
  • Stochastic Oscillator
  • ADXN 47.95
  • JNVR 24.18

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

Share on Social Networks: